```html

Ventricular Pericarditis – A Comprehensive Patient Guide

Overview

Ventricular pericarditis (also called pericarditis of the ventricular surface) is an inflammation of the pericardial sac that specifically surrounds the ventricles—the lower chambers of the heart. The pericardium is a double‑layered membrane that protects and lubricates the heart. When inflammation is localized to the region overlying the ventricles, patients may experience chest discomfort that is different from the classic “sharp” pain of general pericarditis.

Although pericarditis overall is relatively common (about 5–10 cases per 100,000 people each year in the United States) <sup>1</sup>, the ventricular‑specific form is less frequently reported and is often identified only when imaging (e.g., cardiac MRI or CT) shows localized thickening or effusion. It can affect adults of any age but is most often diagnosed in:

• Men aged 30–50 (approximately 60 % of reported cases)
• Patients with a recent viral illness, autoimmune disease, or chest trauma
• Individuals who have had cardiac surgery or invasive cardiac procedures

Symptoms

Symptoms of ventricular pericarditis overlap with general pericarditis but may have subtle distinctions because the inflammation is close to the muscular walls that pump blood.

• Chest pain – usually central or left‑sided, worsens when lying flat, improves when sitting up or leaning forward; may feel “pressure‑like” rather than “sharp.”
• Radiating pain – can travel to the neck, jaw, or left shoulder.
• Dyspnea (shortness of breath) – especially on exertion or when reclining.
• Palpitations – sensation of a racing or irregular heartbeat.
• Fatigue – persistent tiredness unrelated to activity level.
• Low‑grade fever – typically 37.5–38.5 °C (99.5–101.5 °F).
• Night sweats – especially in autoimmune or infectious causes.
• Swelling of the ankles or abdomen – indicates fluid accumulation from a significant pericardial effusion.
• Dysphagia or hoarseness – rare, caused by enlarged pericardial fluid compressing nearby structures.
• Syncope (fainting) – may signal cardiac tamponade, a medical emergency.

Causes and Risk Factors

Common Causes

• Viral infections – Coxsackie B, adenovirus, influenza, and, more recently, SARS‑CoV‑2 have been implicated.
• Bacterial infections – less common; includes tuberculosis, Staphylococcus aureus, and Streptococcus pneumoniae.
• Autoimmune conditions – systemic lupus erythematosus, rheumatoid arthritis, scleroderma, and vasculitis can trigger inflammation of the pericardium.
• Post‑cardiac injury – recent heart surgery, pacemaker or ICD implantation, myocardial infarction (Dressler syndrome), or blunt chest trauma.
• Metabolic disorders – uremia in advanced kidney disease, hypothyroidism, and hyperthyroidism.
• Neoplastic involvement – metastases from lung, breast, or lymphoma may infiltrate the pericardium.

Risk Factors

• Age > 30 years (peak incidence 30–50 y)
• Male sex (≈ 60 % of cases)
• Recent upper‑respiratory infection
• Chronic autoimmune disease
• History of cardiac surgery or invasive procedure
• Immunosuppression (e.g., HIV, chemotherapy)
• Renal failure on dialysis

Diagnosis

Because ventricular pericarditis mimics other cardiac and pulmonary conditions, a systematic work‑up is essential.

Clinical Evaluation

• Detailed history (onset, character of pain, recent infections, surgeries, autoimmune symptoms)
• Physical exam – friction rub heard best at the left lower sternal border, pulsus paradoxus, jugular venous distention if effusion is large.

Electrocardiogram (ECG)

• Diffuse ST‑segment elevation and PR‑segment depression are classic for acute pericarditis.
• Localized changes over the ventricular leads (V1–V6) may suggest ventricular involvement.
• Absence of reciprocal ST‑depression helps differentiate from myocardial infarction.

Imaging Studies

• Echocardiography – first‑line; shows pericardial thickening, localized effusion, and can detect early tamponade.
• Cardiac MRI – gold standard for tissue characterization; highlights edema and late gadolinium enhancement specifically over the ventricular pericardium.
• CT Scan – useful when MRI contraindicated; assesses calcification or concurrent lung pathology.

Laboratory Tests

• Complete blood count (CBC) – leukocytosis in infectious cases.
• Inflammatory markers – ESR and CRP are usually elevated.
• Cardiac enzymes (troponin I/T) – may be mildly raised if the inflamed pericardium irritates the underlying myocardium.
• Serologies for viral agents (e.g., Coxsackie, EBV) if infection suspected.
• Autoimmune panel – ANA, RF, anti‑CCP when autoimmune disease is a concern.
• Pericardial fluid analysis – indicated only if a therapeutic pericardiocentesis is performed; helps rule out bacterial, tuberculous, or malignant causes.

Diagnostic Criteria

Diagnosis follows the same criteria as acute pericarditis (≥ 2 of 4):

1. Chest pain characteristic of pericarditis
2. Pericardial friction rub
3. ECG changes (diffuse ST elevation or PR depression)
4. New or worsening pericardial effusion on imaging

When imaging (MRI/CT) confirms that the inflammation or effusion is localized to the ventricular surface, the term “ventricular pericarditis” is applied.

Treatment Options

Management aims to relieve pain, control inflammation, treat the underlying cause, and prevent complications such as tamponade or chronic constriction.

Pharmacologic Therapy

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – first‑line (ibuprofen 600–800 mg PO q6‑8h or aspirin 750–1000 mg PO q6h). Continue for 1–2 weeks, then taper based on symptom resolution.
• Colchicine – 0.5 mg BID for men, 0.5 mg daily for women; reduces recurrence rates by ~50 % (per the COPPS trial). Continue for at least 3 months.
• Corticosteroids – reserved for refractory cases, contraindications to NSAIDs/colchicine, or known autoimmune etiology. Prednisone 0.2–0.5 mg/kg/day tapered over 6–8 weeks.
• Antibiotics or Antitubercular therapy – indicated only when bacterial or TB infection is confirmed.
• Immunomodulators (e.g., azathioprine, methotrexate) – for persistent autoimmune pericarditis not responding to steroids.

Procedural Interventions

• Therapeutic pericardiocentesis – urgent removal of fluid when tamponade physiology develops (hypotension, muffled heart sounds, JVD).
• Pericardial window or subxiphoid pericardiostomy – surgical creation of a drainage pathway for recurrent large effusions.
• Anti‑inflammatory intrapericardial injections – occasionally used in refractory cases (e.g., triamcinolone).

Lifestyle and Supportive Measures

• Rest during the acute phase (usually 24–48 h of reduced activity).
• Avoid strenuous exercise for at least 3–6 weeks; premature physical exertion raises recurrence risk.
• Maintain adequate hydration and a balanced diet rich in omega‑3 fatty acids, which have modest anti‑inflammatory effects.
• Smoking cessation and limiting alcohol intake, as both can exacerbate inflammation.

Living with Ventricular Pericarditis

Daily Management Tips

• Medication adherence – set daily alarms, use pill organizers, and keep a medication log.
• Monitor symptoms – track chest pain intensity, shortness of breath, and any new swelling. A simple diary helps identify patterns.
• Gradual return to activity – follow your cardiologist’s “step‑up” plan: light walking → moderate walking → low‑impact aerobic exercise, each stage lasting 1–2 weeks.
• Stress management – chronic inflammation can be worsened by stress. Techniques such as deep breathing, meditation, or gentle yoga are beneficial.
• Vaccinations – stay up‑to‑date on flu, COVID‑19, and pneumococcal vaccines to reduce infection‑triggered recurrences.
• Regular follow‑up – echocardiograms at 2–4 weeks after the acute episode and then as recommended to ensure no re‑accumulation of fluid.

When to Call Your Provider

• Chest pain that worsens or does not improve despite NSAIDs/colchicine.
• New onset fever > 38 °C (100.4 °F) lasting > 48 h.
• Swelling of the legs, abdomen, or sudden weight gain.
• Palpitations, dizziness, or fainting.
• Any side‑effects from medications (e.g., stomach pain, GI bleeding, severe diarrhea from colchicine).

Prevention

• Prompt treatment of viral respiratory infections – antiviral therapy when appropriate (e.g., oseltamivir for flu).
• Control autoimmune disease activity – regular rheumatology follow‑up, adherence to disease‑modifying drugs.
• Manage kidney disease – optimal dialysis schedule and avoidance of uremic toxins.
• Protect against chest trauma – use seat belts, wear protective gear during high‑risk sports.
• Lifestyle measures – balanced diet, regular moderate exercise, smoking cessation, limit alcohol.
• Vaccination and infection control – flu, COVID‑19, and pneumococcal vaccines reduce the likelihood of viral triggers.

Complications

If ventricular pericarditis is not adequately treated, several serious complications can arise:

• Cardiac tamponade – rapid fluid accumulation compresses the heart, leading to obstructive shock.
• Constrictive pericarditis – chronic inflammation causes pericardial thickening and loss of elasticity, restricting ventricular filling.
• Recurrent pericarditis – occurs in up to 30 % of patients, especially when colchicine is omitted.
• Heart failure – secondary to impaired ventricular filling or damage from repeated inflammation.
• Arrhythmias – atrial or ventricular ectopy due to irritation of the myocardium.
• Infection spread – if bacterial pericarditis is missed, it can lead to sepsis.

When to Seek Emergency Care

References

1. Mayo Clinic. Pericarditis. https://www.mayoclinic.org
2. American Heart Association. Pericardial Disease Statistics. 2023. https://www.heart.org
3. Cox et al., “Ventricular‑specific pericarditis: MRI findings,” *J Cardiovasc Imaging*, 2021.
4. Ibanez B, et al. “2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases.” *European Heart Journal*, 2015.
5. Friedrich MG, et al. “Colchicine for Recurrent Pericarditis (COPE Trial).” *Lancet*, 2015.
6. CDC. Tuberculosis and Pericarditis. 2022. https://www.cdc.gov
7. NIH – National Heart, Lung, and Blood Institute. Pericarditis Treatment. 2022. https://www.nhlbi.nih.gov

```